Company: XORTX Therapeutics Inc.
CEO: Dr. Allen W. Davidoff, CEO
XORTX Therapeutics Inc. Presentation
XORTX Therapeutics Inc. Interview
XORTX Therapeutics Inc. Elevator Pitch
For a PDF of the Slide Presentations Click Here
XORTX Therapeutics Inc. is a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. XORTX has lead programs to develop treatments for progressive kidney disease due to diabetes, diabetic nephropathy and polycystic kidney disease with secondary programs focused on developing therapies for health consequences that accompany pre-diabetes, diabetes and cardiovascular disease. At XORTX Therapeutics, we are dedicated to developing medications to improve the quality of life and future health of patients.
Head Office: 421 – 7th Avenue SW, Suite 4000, Calgary, AB, CAN, T2P 4K9
P: 1 403 607-2621